Brief: 60 Degrees Pharmaceuticals Company Regained Compliance With Nasdaq Minimum Bid Price
12/02/2026 14:32
Feb 12 (Reuters) - 60 Degrees Pharmaceuticals Inc SXTP.O: 60 DEGREES PHARMACEUTICALS INC - COMPANY REGAINED COMPLIANCE WITH NASDAQ MINIMUM BID PRICE - SEC FILING Source text: [ID:n0001213900-26-015239] Further company coverage: SXTP.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on 60 Degrees Pharmaceuticals
See all newsBrief: 60 Degrees Pharmaceuticals Says May Submit NDA For Tafenoquine To FDA Before End Of Q1 2028 - SEC Filing
U.S. RESEARCH ROUNDUP-Analog Devices, Intuit, NVIDIA
Brief: 60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (Ndin) With FDA For Australian Chestnut Extract
NASDAQ RESUMED AT 10:06 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:55 AM